Detalles de la búsqueda
1.
Unraveling MCL biology to understand resistance and identify vulnerabilities.
Blood
; 2024 Mar 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551811
2.
A p53 score derived from TP53 CRISPR/Cas9 HMCLs predicts survival and reveals a major role of BAX in the response to BH3 mimetics.
Blood
; 143(13): 1242-1258, 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38096363
3.
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
Blood
; 2024 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669626
4.
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Blood
; 142(18): 1543-1555, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37562004
5.
Quad-class exposed/refractory myeloma is associated with short survival.
Br J Haematol
; 204(1): 186-190, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37833834
6.
Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385294
7.
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Haematologica
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497158
8.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385243
9.
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.
Am J Hematol
; 99(3): 350-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165016
10.
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Blood
; 137(7): 877-887, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33181832
11.
Epidemiology and Clinical Impact of Respiratory Coinfections at Diagnosis of Pneumocystis jirovecii Pneumonia.
J Infect Dis
; 225(5): 868-880, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34604908
12.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
J Antimicrob Chemother
; 77(9): 2546-2556, 2022 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35748614
13.
The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition.
Haematologica
; 107(12): 2905-2917, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35263985
14.
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
Haematologica
; 107(9): 2163-2172, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172560
15.
Grade 2 acute GVHD is a factor of good prognosis in patients receiving peripheral blood stem cells haplo-transplant with post-transplant cyclophosphamide.
Acta Oncol
; 60(4): 466-474, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33112687
16.
Regulatory T Cells Expressing Tumor Necrosis Factor Receptor Type 2 Play a Major Role in CD4+ T-Cell Impairment During Sepsis.
J Infect Dis
; 222(7): 1222-1234, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32697326
17.
Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review.
Br J Haematol
; 189(5): 869-878, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32191819
18.
BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment.
Blood
; 132(25): 2656-2669, 2018 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30309889
19.
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
Hematol Oncol
; 38(4): 446-455, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32472610
20.
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T3 phase IB trial of the LYSA.
Ann Hematol
; 99(8): 1771-1778, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32601796